human
within
betacoronaviru
genu
famili
coronavirida
envelop
posit
sens
rna
five
known
genotyp
betacoronavirus
includ
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
preval
among
human
genotyp
promin
recent
littl
known
genotyp
persist
human
popul
continu
adapt
viral
antigen
gene
spike
protein
genet
drift
may
necessari
spike
protein
major
antigen
protein
select
pressur
host
immun
respons
import
host
rang
tissu
tropism
cleav
subunit
receptor
bind
membran
fusion
domain
subunit
respons
sugar
receptor
bind
subunit
respons
fusion
viral
host
subunit
diverg
sequenc
subunit
human
coronavirus
caus
common
cold
ill
associ
sever
ill
pneumonia
exacerb
asthma
chronic
obstruct
pulmonari
diseas
croup
bronchiol
patient
chronic
obstruct
pulmonari
diseas
studi
influenza
season
ill
associ
infect
anoth
studi
acut
respiratori
ill
patient
cardiopulmonari
diseas
healthi
young
adult
associ
ill
less
sever
influenza
associ
multipl
respiratori
system
symptom
infect
rate
healthi
young
elderli
adult
adult
hospit
patient
report
winter
contribut
medic
diseas
littl
known
degre
heterogen
viral
present
upper
respiratori
secret
present
may
help
explain
persist
incid
infect
human
popul
mutat
chang
result
antigen
drift
might
allow
escap
host
immun
contribut
viru
infect
pathogen
current
studi
combin
illumina
sequenc
measur
divers
spike
gene
direct
count
spike
gene
mutat
determin
percent
nonsynonym
mutat
rate
comparison
rate
hcv
genu
hepaciviru
famili
flavivirida
hcv
rna
viru
heterogen
popul
chronic
infect
studi
nasal
oropharyng
swab
specimen
obtain
four
patient
earli
symptomat
acut
respiratori
ill
posit
nucleic
acid
multiplex
serum
nasal
wash
specimen
obtain
time
acut
ill
week
ill
onset
assay
immunosorb
assay
serum
igg
nasal
wash
iga
antibodi
tissu
american
type
cultur
collect
genbank
inactiv
psoralen
compound
ultraviolet
light
sever
acut
respiratori
ill
measur
two
score
visual
analogu
scale
overal
ill
sever
rang
mildest
sever
sever
symptom
sign
score
sum
symptom
sign
grade
scale
absent
sever
maximum
score
respiratori
system
symptom
acut
ill
record
patient
gave
written
inform
consent
studi
approv
institut
review
board
va
st
loui
health
care
system
saint
loui
univers
two
recombin
clone
previou
studi
contain
bp
hcv
insert
use
estim
potenti
error
associ
illumina
also
hcv
genotyp
sampl
earlier
avail
comparison
current
studi
total
rna
nasal
oropharyng
swab
specimen
sampl
purifi
use
qiaamp
ultrasen
viru
kit
qiagen
valencia
ca
accord
manufactur
procedur
appli
amplifi
bp
amplicon
span
spike
gene
bp
brief
extract
rna
mix
rt
matrix
consist
superscript
iii
buffer
mm
dtt
revers
primer
ccc
aca
tac
cac
aca
posit
number
accord
strain
genbank
access
number
mm
dntp
u
rnase
recombin
ribonucleas
inhibitor
u
superscript
iii
revers
transcriptas
life
technolog
min
incub
subsequ
inactiv
aliquot
rt
reaction
appli
first
round
pcr
contain
gc
enhanc
new
england
biolab
buffer
new
england
biolab
mm
dntp
forward
primer
cag
gtt
gtt
gat
tcg
posit
u
high
fidel
dna
polymeras
new
england
biolab
initi
heat
min
cycl
paramet
program
first
cycl
sec
sec
min
follow
cycl
sec
sec
min
sec
autoextens
cycl
two
first
round
pcr
product
use
second
round
amplif
primer
forward
primer
ggc
ctc
tct
acc
cct
atg
posit
revers
primer
gat
tac
ggc
acc
aag
cat
posit
cycl
paramet
first
round
pcr
product
expect
size
use
qiaquick
pcr
purif
kit
qiagen
quantit
purifi
dna
product
subject
librari
construct
fragment
librari
construct
use
illumina
nextera
xt
dna
librari
prepar
kit
follow
illumina
sequenc
nextseq
machin
bp
read
output
first
estim
error
rate
associ
illumina
sequenc
use
two
recombin
hcv
clone
raw
sequenc
read
fastq
format
first
filter
prinseq
v
qualiti
control
includ
read
length
bp
mean
read
qualiti
score
low
complex
dust
score
ambigu
base
filter
read
map
onto
hcv
genotyp
prototyp
strain
genbank
access
number
use
gap
align
bowti
map
file
convert
binari
format
bam
sort
index
follow
local
realign
base
qualiti
recalibr
genom
analysi
toolkit
gatk
next
convert
bam
file
mpileup
format
samtool
consensu
sequenc
clone
call
varscan
v
set
x
coverag
base
qualiti
posit
count
read
mutat
entir
pipelin
repeat
use
individu
consensu
sequenc
mutat
call
posit
varscan
set
frequenc
base
qualiti
follow
manual
check
integr
genom
use
valu
base
qualiti
defin
mutat
analysi
similar
procedur
appli
four
patient
sampl
strain
genbank
use
refer
initi
map
entir
coronaviru
spike
gene
mutat
load
total
number
mutat
given
site
count
slide
window
size
bp
overlap
bp
final
frame
hcov
spike
gene
bp
natur
mutat
either
synonym
nonsynonym
determin
use
custom
consensu
hcov
spike
sequenc
four
patient
refer
sequenc
retriev
genbank
use
phylogenet
analysi
tree
construct
use
approach
nucleotid
substitut
model
maximum
composit
likelihood
mega
program
version
statist
analys
done
either
unpair
student
test
applic
data
express
mean
valu
standard
deviat
p
consid
statist
signific
raw
sequenc
data
fastq
format
four
patient
sampl
archiv
ncbi
sequenc
read
archiv
sra
sra
access
number
sampl
genotyp
collect
within
month
decemb
januari
two
older
patient
signific
acut
respiratori
system
symptom
tabl
patient
underli
chronic
cardiopulmonari
diseas
diabet
mellitu
two
ill
associ
greater
fourfold
increas
nasal
wash
iga
antibodi
titer
one
least
fourfold
increas
serum
igg
antibodi
titer
compar
acut
ill
convalesc
specimen
collect
week
ill
onset
tabl
sampl
subject
two
genotyp
b
collect
year
apart
januari
march
younger
patient
without
underli
chronic
ill
older
patient
cardiac
diseas
diabet
mellitu
acut
respiratori
system
symptom
may
less
sever
report
two
patient
genotyp
isol
tabl
one
two
ill
genotyp
b
virus
associ
greater
fourfold
increas
nasal
wash
iga
antibodi
titer
neither
fourfold
rise
serum
igg
antibodi
titer
compar
acut
ill
convalesc
specimen
collect
week
ill
onset
tabl
raw
data
output
indic
base
read
qualiti
score
greater
interpret
distribut
statist
base
qualiti
score
read
length
result
trim
read
length
end
final
result
qualiti
control
shown
supplement
tabl
larg
output
gave
deep
base
coverag
hcov
sampl
averag
supplement
fig
estim
error
rate
associ
librari
construct
illumina
sequenc
mutat
call
two
recombin
hcv
clone
rang
base
qualiti
set
even
mutat
count
base
qualiti
low
differ
consensu
sequenc
deriv
either
illumina
sanger
sequenc
data
shown
howev
number
individu
mutat
sharp
drop
base
qualiti
supplement
fig
condit
mutat
frequenc
base
qualiti
score
total
mutat
two
hcv
clone
sampl
suggest
error
rate
mutat
per
kb
appli
criteria
coronaviru
sampl
total
mutat
four
sampl
identifi
averag
number
mutat
rang
mutat
per
sampl
significantli
higher
expect
illumina
sequenc
error
rate
vs
mutat
p
nonsynonym
mutat
account
total
mutat
tabl
delet
recombin
detect
viral
mutat
frequenc
greater
occur
six
posit
spike
gene
posit
number
tabl
use
slide
window
analysi
window
size
bp
overlap
bp
two
mutat
peak
one
end
spike
gene
posit
number
fig
use
consensu
sequenc
tree
show
phylogenet
two
subject
sampl
genotyp
two
genotyp
b
strain
fig
b
two
genotyp
b
sampl
high
mutat
frequenc
spike
gene
nucleotid
posit
wherea
two
genotyp
sampl
mutat
frequenc
posit
less
posit
previous
report
studi
found
hcv
genotyp
patient
experienc
relaps
antivir
treatment
n
higher
averag
total
mutat
load
measur
sampl
current
studi
use
base
qualiti
score
rather
earlier
averag
mutat
load
hcv
patient
isol
significantli
higher
patient
isol
vs
p
howev
nonsynonym
mutat
percentag
total
mutat
higher
among
isol
among
hcv
genotyp
patient
isol
vs
p
align
spike
gene
consensu
amino
acid
sequenc
show
differ
four
clinic
strain
prototyp
strain
particularli
n
c
termin
end
subunit
subunit
cleavag
site
aa
smaller
number
amino
acid
differ
subunit
fig
high
genet
mutat
rate
site
correspond
sever
amino
acid
chang
compar
prototyp
strain
amino
acid
posit
illumina
sequenc
introduc
spike
gene
mutat
load
quantifi
viral
popul
divers
experiment
method
allow
role
spike
gene
heterogen
investig
manner
previous
report
spike
gene
magnitud
almost
time
lower
found
hcv
nonsynonym
mutat
take
higher
percentag
total
mutat
load
hcv
genotyp
note
spike
gene
amplifi
primer
although
primer
locat
conserv
hcov
domain
miss
potenti
heterogen
viral
variant
amplif
exclud
consequ
divers
hcov
may
underestim
current
studi
comparison
use
degener
primer
approach
viral
replic
dynam
popul
size
host
immun
respons
may
contribut
observ
find
implic
term
hcov
evolut
treatment
high
mutat
load
facilit
evolut
viral
popul
respons
extern
pressur
given
slightli
deleteri
natur
howev
excess
nonsynonym
mutat
detriment
adapt
consequ
accumul
deleteri
mutat
load
viral
infect
may
contribut
activ
infect
case
could
contribut
short
respiratori
tract
infect
compar
hcv
chronic
system
viral
infect
ongo
viral
replic
howev
genet
divers
manifest
cloud
viral
system
link
pathogen
shown
allow
adapt
new
environ
infect
new
clonal
viru
popul
present
human
infect
could
increas
chanc
epidem
spread
particularli
virul
infect
cloud
viral
strain
may
enhanc
spread
instanc
increas
chanc
virul
strain
transmit
reduc
due
defect
less
virul
strain
present
genom
sequenc
dromedari
camel
indic
presenc
singl
recent
deep
sequenc
analys
report
viral
heterogen
outbreak
possibl
host
immun
respons
provid
select
pressur
favor
genet
viral
heterogen
may
contribut
four
clinic
isol
genotyp
b
describ
circul
recent
year
rather
genotyp
align
spike
gene
consensu
amino
acid
sequenc
compar
prototyp
strain
sequenc
genotyp
indic
major
chang
subunit
proteolyt
cleavag
site
subunit
four
clinic
strain
studi
rrsrr
motif
rather
rrsrg
motif
prototyp
strain
g
r
substitut
amino
acid
may
result
increas
cleavabl
cleavag
process
may
play
part
fusion
activ
viral
minim
amino
acid
chang
spike
gene
nucleotid
posit
whole
genom
posit
glomerular
part
spike
gene
encod
tqdg
aa
posit
low
mutat
frequenc
region
four
clinic
isol
although
four
substitut
lectin
domain
subunit
involv
attach
viru
cellular
receptor
deriv
neuramin
tqdg
sequenc
may
evolutionari
function
import
present
close
relat
bovin
coronavirus
insert
strain
four
critic
residu
present
isol
correspond
bovin
coronaviru
domain
around
receptor
bind
motif
involv
amino
acid
area
nonsynonym
substitut
genet
divers
occur
isol
sequenc
area
import
bind
affin
human
enzym
two
host
immun
isol
nonsynonym
substitut
amino
acid
residu
domain
particular
nonsynonym
amino
acid
substitut
within
region
amino
acid
put
receptor
bind
domain
aa
posit
hcov
strain
instanc
antibodi
neutral
viru
depend
antigen
phenotyp
subunit
henc
may
also
factor
need
studi
patient
acut
upper
respiratori
system
sign
symptom
small
number
evalu
preclud
conclus
pathogen
viral
mutat
rate
pattern
approach
open
pathway
futur
studi
conclus
present
strain
involv
area
subunit
spike
gene
may
affect
evolut
viral
bind
process
antigen
well
host
specif
studi
need
fulli
character
extent
clinic
isol
relat
diseas
characterist
host
immun
respons
nonsynonym
mutat
frequent
synonym
one
contribut
hypothesi
mutat
import
viral
persist
human
popul
time
diseas
pathogenesi
